Profile data is unavailable for this security.
About the company
Lionco Pharmaceutical Group Co.,Ltd. is a China-based company principally engaged in the research and development, production and sales of chemical prescription medicine. The Company's products are mainly categorized in to three areas: parenteral nutrition agents, anti-infectious agents and digestive system agents. The lead product of its parenteral nutrition agents is Glutamine for injection; its anti-infectious agents include Cefodizime sodium for injection and Cefathiamidine for injection, among others; its digestive system agents include Omeprazole Sodium for injection and others. The Company operates its business in domestic market.
- Revenue in CNY (TTM)200.39m
- Net income in CNY-144.55m
- Incorporated2003
- Employees475.00
- LocationLionco Pharmaceutical Group Co LtdMedicine Valley Industrial ParkNo. 16 Medicine Valley Erheng RoadNational Hi-tech Industrial Dvlpmnt ZneSHANNAN 856000ChinaCHN
- Phone+86 8 937830999
- Fax+86 8 937830888
- Websitehttp://www.lingkang.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jiangsu Yahong Meditech Co Ltd | 38.05m | -420.35m | 3.43bn | 394.00 | -- | 1.49 | -- | 90.18 | -0.7375 | -0.7375 | 0.0668 | 4.03 | 0.0142 | 3.05 | 3.76 | 96,573.63 | -15.68 | -15.80 | -16.54 | -16.48 | 77.72 | 55.32 | -1,106.10 | -9,445.91 | 11.34 | -- | 0.0684 | -- | 52,594.79 | -- | -62.42 | -- | 64.28 | -- |
Lionco Pharmaceutical Group Co Ltd | 200.39m | -144.55m | 3.60bn | 475.00 | -- | 3.92 | -- | 17.96 | -0.2071 | -0.2071 | 0.2826 | 1.27 | 0.1182 | 1.86 | 2.52 | 421,872.40 | -8.52 | 0.7396 | -9.94 | 0.9562 | 42.74 | 80.88 | -72.13 | 2.08 | 6.19 | -5.98 | 0.3512 | 521.93 | -31.95 | -34.79 | 22.65 | -- | -33.18 | -- |
Qingdao Vland Biotech INC | 1.25bn | 82.87m | 3.65bn | 1.57k | 43.36 | 2.12 | -- | 2.91 | 0.3326 | 0.3326 | 5.02 | 6.81 | 0.4431 | 3.42 | 4.33 | 797,663.40 | 3.80 | 5.78 | 5.77 | 7.89 | 45.38 | 46.13 | 8.58 | 10.34 | 0.8387 | 149.27 | 0.2896 | 33.59 | 3.07 | 8.05 | 15.56 | -0.6507 | 24.68 | -6.89 |
Obio Technology Shanghai Corp Ltd | 233.59m | -138.37m | 3.66bn | 731.00 | -- | 1.81 | -- | 15.66 | -0.2157 | -0.2157 | 0.3624 | 3.11 | 0.0921 | 3.37 | 2.52 | 319,545.50 | -5.45 | 0.2246 | -5.99 | 0.2514 | -9.53 | 36.72 | -59.21 | 1.48 | 2.39 | -- | 0.1103 | 0.00 | -29.69 | 35.88 | -425.90 | -- | 57.00 | -- |
Zhejiang Starry Pharmaceutical Co Ltd | 2.27bn | 46.95m | 3.82bn | 1.85k | 81.57 | 2.17 | -- | 1.68 | 0.1368 | 0.1368 | 6.63 | 5.15 | 0.4179 | 1.98 | 5.09 | 1,231,642.00 | 0.8789 | 3.30 | 1.80 | 5.97 | 23.86 | 32.35 | 2.10 | 8.21 | 0.4121 | 1.44 | 0.6405 | 53.08 | 3.04 | 19.78 | 158.32 | -13.94 | 10.39 | -- |
Data as of May 31 2024. Currency figures normalised to Lionco Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
China Asset Management Co., Ltd.as of 31 Dec 2023 | 3.72m | 0.52% |
Gfund Management Co., Ltd.as of 31 Dec 2023 | 1.98m | 0.28% |
SWS MU Fund Management Co., Ltd.as of 31 Dec 2023 | 1.26m | 0.18% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.